1. Preliminary In Vivo Evidence of Reduced Synaptic Density in Human Immunodeficiency Virus (HIV) Despite Antiretroviral Therapy
- Author
-
Serena Spudich, Rachela M. Calvi, Julian J Weiss, Takuya Toyonaga, Jim Ropchan, Ming-Qiang Zheng, Yiyun Huang, Jennifer Chiarella, Robert H. Pietrzak, Richard E. Carson, Michelle Chintanaphol, Mika Naganawa, and Shelli F. Farhadian
- Subjects
Microbiology (medical) ,Oncology ,Male ,medicine.medical_specialty ,brain ,Pilot Projects ,HIV Infections ,Frontostriatal circuit ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Humans ,030212 general & internal medicine ,SV2A ,Aged ,NeuroHIV ,medicine.diagnostic_test ,business.industry ,Diagnostic Tests, Routine ,HIV ,Magnetic resonance imaging ,synaptic density ,Motor coordination ,Major Articles and Commentaries ,Infectious Diseases ,medicine.anatomical_structure ,Cross-Sectional Studies ,AcademicSubjects/MED00290 ,PET ,Positron emission tomography ,Positron-Emission Tomography ,Biomarker (medicine) ,Neuropathogenesis ,business ,Neurocognitive ,030217 neurology & neurosurgery - Abstract
Background Synaptic injury is a pathological hallmark of neurological impairment in people living with human immunodeficiency virus (HIV, PLWH), a common complication despite viral suppression with antiretroviral therapy (ART). Measurement of synaptic density in living humans may allow better understanding of HIV neuropathogenesis and provide a dynamic biomarker for therapeutic studies. We applied novel synaptic vesical protein 2A (SV2A) positron emission tomographic (PET) imaging to investigate synaptic density in the frontostriatalthalamic region in PLWH and HIV-uninfected participants. Methods In this cross-sectional pilot study,13 older male PLWH on ART underwent magnetic resonance imaging (MRI) and PET scanning with the SV2A ligand [11C]UCB-J with partial volume correction and had neurocognitive assessments. SV2A binding potential (BPND) in the frontostriatalthalamic circuit was compared to 13 age-matched HIV-uninfected participants and assessed with respect to neurocognitive performance in PLWH. Results PLWH had 14% lower frontostriatalthalamic SV2A synaptic density compared to HIV-uninfected (PLWH: mean [SD], 3.93 [0.80]; HIV-uninfected: 4.59 [0.43]; P = .02, effect size 1.02). Differences were observed in widespread additional regions in exploratory analyses. Higher frontostriatalthalamic SV2A BPND associated with better grooved pegboard performance, a measure of motor coordination, in PLWH (r = 0.61, P = .03). Conclusions In a pilot study, SV2A PET imaging reveals reduced synaptic density in older male PLWH on ART compared to HIV-uninfected in the frontostriatalthalamic circuit and other cortical areas. Larger studies controlling for factors in addition to age are needed to determine whether differences are attributable to HIV or comorbidities in PLWH. SV2A imaging is a promising biomarker for studies of neuropathogenesis and therapeutic interventions in HIV., Understanding of the biological substrates of neurological impairment in people with human immunodeficiency virus (HIV) is limited. Here, novel in vivo SV2A positron emission tomographic (PET) imaging demonstrated lower synaptic density in older men with virologically suppressed HIV, potentially revealing a new biomarker of neurologic injury.
- Published
- 2021